Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD

Luzia Baumeler, Eleni Papakonstantinou, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim G. Aerts, Tobias Welte, Konstantinos Kostikas, Francesco Blasi, Wim Boersma, Antoni Torres, Gernot G. U. Rohde, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm, Daiana Stolz*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)883-890
Issue number5
Publication statusPublished - Jul 2016


  • anti-gastroesophageal reflux disease therapy
  • chronic obstructive pulmonary disease
  • chronic obstructive pulmonary disease exacerbations
  • gastroesophageal reflux disease
  • proton pump inhibitors

Cite this